XML 102 R66.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Information by segment and main country - Reconciliation from net income to Adjusted EBITA (Detail) - EUR (€) € in Millions | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) |  | € (463) | [1] | € (1,605) | [2] | € 3,323 | [2]
Profit (loss) from discontinued operations |  | (10) | [2] | 13 | [2] | 2,711 | [1]
Tax expense (income) |  | (73) |  | (113) |  | (103) |
Share of profit (loss) of associates and joint ventures accounted for using equity method |  | (98) |  | (2) |  | (4) |
Finance costs |  | 376 |  | 258 |  | 188 |
Finance income |  | 63 |  | 58 |  | 149 |
Profit (loss) from operating activities |  | (115) |  | (1,529) |  | 553 |
Amortization of acquired intangible assets | [2] | 290 |  | 363 |  | 322 |
Impairment loss recognised in profit or loss, goodwill | [2] | 8 |  | 1,357 |  | 15 |
Earnings before interest, taxes and amortization |  | 183 |  | 192 |  | 890 |
Restructuring and acquisition-related charges | [2] | 381 |  | 202 |  | 95 |
Other items | [2] | 1,358 |  | 925 |  | 1,069 |
Adjusted EBITA |  | 1,921 |  | 1,318 |  | 2,054 |
Respironics litigation provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 575 |  |  |  |  |
Respironics field-action connected to the anticipated consent decree [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 363 |  | 250 |  | 719 |
Respironics field-action running remediation costs [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 224 |  | 210 |  | 94 |
Quality remediation actions [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 175 |  | 59 |  | 94 |
Provision for a legal matter [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 31 |  |  |  |  |
Investment re-measurement loss [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 23 |  |  |  |  |
Gain on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | (35) |  |  |  |  |
Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] | 2 |  | 63 |  | 87 |
R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  | 134 |  |  |
Portfolio realignment charges [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  | 109 |  |  |
Provision for public investigations tender irregularities [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  | 60 |  |  |
Impairment of assets in S&RC [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  | 39 |  |  |
Loss on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items | [2] |  |  |  |  | 76 |
Diagnosis & Treatment [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | 720 |  | 538 |  | 948 |
Amortization of acquired intangible assets |  | 89 |  | 115 |  | 142 |
Impairment loss recognised in profit or loss, goodwill |  | 8 |  |  |  | 2 |
Earnings before interest, taxes and amortization |  | 816 |  | 652 |  | 1,092 |
Restructuring and acquisition-related charges |  | 118 |  | 3 |  | (30) |
Other items |  | 92 |  | 133 |  | (35) |
Adjusted EBITA |  | 1,026 |  | 788 |  | 1,028 |
Diagnosis & Treatment [Member] | Quality remediation actions [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 81 |  |  |  |  |
Diagnosis & Treatment [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 11 |  | 0 |  | (35) |
Diagnosis & Treatment [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 73 |  |  |
Diagnosis & Treatment [Member] | Provision for public investigations tender irregularities [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 60 |  |  |
Connected Care [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | (1,199) |  | (2,347) |  | (716) |
Amortization of acquired intangible assets |  | 178 |  | 226 |  | 158 |
Impairment loss recognised in profit or loss, goodwill |  | 0 |  | 1,357 |  | 13 |
Earnings before interest, taxes and amortization |  | (1,020) |  | (764) |  | (545) |
Restructuring and acquisition-related charges |  | 115 |  | 125 |  | 130 |
Other items |  | 1,275 |  | 750 |  | 968 |
Adjusted EBITA |  | 369 |  | 111 |  | 553 |
Connected Care [Member] | Respironics litigation provision [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 575 |  |  |  |  |
Connected Care [Member] | Respironics field-action connected to the anticipated consent decree [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 363 |  | 250 |  | 719 |
Connected Care [Member] | Respironics field-action running remediation costs [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 224 |  | 210 |  | 94 |
Connected Care [Member] | Quality remediation actions [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 94 |  | 59 |  | 94 |
Connected Care [Member] | Provision for a legal matter [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 31 |  |  |  |  |
Connected Care [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | (12) |  | 24 |  | 61 |
Connected Care [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 59 |  |  |
Connected Care [Member] | Portfolio realignment charges [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 109 |  |  |
Connected Care [Member] | Impairment of assets in S&RC [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 39 |  |  |
Personal Health [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | 552 |  | 515 |  | 576 |
Amortization of acquired intangible assets |  | 14 |  | 15 |  | 15 |
Earnings before interest, taxes and amortization |  | 567 |  | 531 |  | 591 |
Restructuring and acquisition-related charges |  | 9 |  | 11 |  | (1) |
Other items |  | 22 |  | (4) |  | 0 |
Adjusted EBITA |  | 597 |  | 538 |  | 590 |
Personal Health [Member] | Investment re-measurement loss [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | 23 |  |  |  |  |
Personal Health [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | (1) |  | (6) |  | 0 |
Personal Health [Member] | R&D project impairments [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  | 3 |  |  |
Other [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Profit (loss) from operating activities |  | (188) |  | (235) |  | (255) |
Amortization of acquired intangible assets |  | 9 |  | 8 |  | 6 |
Earnings before interest, taxes and amortization |  | (179) |  | (227) |  | (248) |
Restructuring and acquisition-related charges |  | 140 |  | 62 |  | (5) |
Other items |  | (32) |  | 46 |  | 136 |
Adjusted EBITA |  | (71) |  | (119) |  | (117) |
Other [Member] | Gain on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | (35) |  |  |  |  |
Other [Member] | Remaining items [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  | € 3 |  | € 46 |  | 61 |
Other [Member] | Loss on divestment of business [Member] |  |  |  |  |  |  |
Information by segment and main country [Line Items] |  |  |  |  |  |  |
Other items |  |  |  |  |  | € 76 |
[1] | Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.
[2] | Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of income associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinanceIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B67 -Subparagraph d -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2023-01-01 -Paragraph 35 -Subparagraph b -Clause viii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph h -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 79 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 81 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Paragraph 81 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B13 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_IncomeTaxExpenseContinuingOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 18 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2023-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2023-01-01 -Paragraph 24 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard -URIDate 2023-03-23 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 17 -IssueDate 2023-01-01 -Paragraph 113 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard -URIDate 2023-03-23 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 81A -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard -URIDate 2023-03-23 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 106 -Subparagraph d -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProfitLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2023-01-01 -Paragraph 33 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph B12 -Subparagraph b -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph ea -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_ea&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 98 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProfitLossFromDiscontinuedOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 32 -IssueDate 2023-01-01 -Paragraph IE33 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProfitLossFromOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2023-01-01 -Paragraph 23 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 82 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_AdjustedEbita
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_AmortizationOfAcquiredIntangibleAssets
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EarningsBeforeInterestTaxesAndAmortization
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_InformationBySegmentAndMainCountryLineItems
Namespace Prefix: | phg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_OtherItems
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_RestructuringAndAcquisitionRelatedCharges
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RespironicsLitigationProvisionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RespironicsFieldActionConnectedToAnticipatedConsentDecreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RespironicsFieldActionRunningRemediationCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_QualityRemediationActionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ProvisionForLegalMatterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_InvestmentReMeasurementLossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_GainOnDivestmentOfBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RemainingItemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_RDProjectImpairmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_PortfolioRealignmentChargesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ProvisionForPublicInvestigationsTenderIrregularitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_ImpairmentOfAssetsInSRcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | phg_AdjustedEbitaOtherItemsAxis=phg_LossOnDivestmentOfBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_DiagnosisTreatmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_ConnectedCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_PersonalHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |